Unknown Primary test
Determine the origin of tumors in patients with cancer of unknown primary or uncertain diagnosis using advanced DNA and RNA profiling. The Unknown Primary test can be seamlessly integrated into the BostonGene Tumor Portrait® order for a more precise diagnosis.
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
Resolving diagnostic uncertainty with advanced DNA and RNA profiling
The BostonGene Unknown Primary test utilizes AI-powered analysis of patients' molecular data to clarify challenging diagnoses and guide the selection of cancer-specific treatments.
.webp)
The 32 most common solid tumors can be identified
Melanoma
Neuroendocrine tumor
Ovarian cancer
Sarcoma
Germ cell neoplasm
Pheochromocytoma
Thymoma
Liver neoplasm
Thyroid neoplasm
Uterine corpus endometrial carcinoma
Lung adenocarcinoma
Pancreatic adenocarcinoma
Urinary bladder urothelial carcinoma
Prostate adenocarcinoma
Unknown Primary test: case example
Male, 81 y.o. at diagnosis. Poorly differentiated metastatic carcinoma with sarcomatoid elements
View our publication
Tumor origin and key actionable biomarkers in one report
All relevant information at-a-glance
.webp)
.webp)
.webp)
.webp)
.webp)
The powerful synergy of AI and pathologist expertise for tailored treatment plans
Each Unknown Primary report is independently validated by a certified pathologist to ensure precise tumor origin prediction. BostonGene also offers the option to update the Tumor Portrait report, incorporating cancer-specific findings and tailored treatment recommendations.
-(1).webp)
Two tests from one tissue sample
- Tumor Portrait test - comprehensive genomic profiling
- Unknown Primary test - tumor origin prediction
No extra tissue
Optional add-on for Tumor Portrait test
